|
Below are BioHealth Innovation News' most popular articles from 2013:
View Presentation
Richard Bendis will be a speaker at the South by Southwest (SXSW) Conference which takes place from March 8-17 in Austin, Texas. SXSW is a set of film, interactive, and music festivals which occur every year in March. Mr. Bendis will be speaking on March 9th at a session titled "Entrepreneurs in Residence: Not Just for VCs." In his presentation, Richard will introduce the BioHealth Innovation, Inc. EIR program and speak about some of the commercialization challenges being addressed creatively by the biohealth community in Maryland.
back to top 
BHI Also Announces Agreement With BD to Create Entrepreneur-in-Residence Position
Rick Ivey, BD Diagnostics
BioHealth Innovation, Inc. (BHI) today announced the fiscal year 2013-2014 election of officers and a new appointment to its Board of Directors. BHI also announced it has entered into an agreement with BD (Becton, Dickinson and Company) to establish an entrepreneur-in-residence (EIR) position at the National Institutes of Health (NIH) Office of Technology Transfer. In conjunction with this agreement, BD is entitled to a voting position on the BHI Board of Directors, which will be held by Richard M. “Rick” Ivey, Worldwide Vice President Research & Development, BD Diagnostics - Diagnostic Systems.
"I am pleased to welcome the new roster of officers and a new member to the BHI Board of Directors," said Richard Bendis, BHI President and CEO. "The officers are a committed group of individuals who already have contributed to the steady growth of BHI, and will continue to be important leaders as the organization further develops."
"Rick Ivey joins the Board on behalf of BD as part of the terms of an agreement between BHI and BD to establish an NIH EIR position,” added Mr. Bendis. “He represents an important new addition to our Board as he is a seasoned medical technology executive who can offer experience and insights to the growing cadre of start-up diagnostics companies in the State of Maryland."
back to top
 ROCKVILLE, MARYLAND, June 4, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, is proud to announce the publication of the Central Maryland BioHealth Entrepreneur's Resource and Finance Guide 2013. The Guide was developed by BHI, the Economic Alliance of Greater Baltimore and the Montgomery County Department of Economic Development, in collaboration with the Baltimore Business Journal.
The Guide serves as a compendium of resources to biohealth innovators and entrepreneurs working to start and grow new companies and technologies in the region. This essential entrepreneurial resource includes a compilation of information on financial resources, university facilities and programs, economic development programs, and existing federal laboratory facilities and programs, as well as how to work with these assets. The Guide is one of the many projects BHI is developing to successfully transform the regional environment for biohealth startups through harnessing Central Maryland's biohealth assets and establishing an entrepreneurial ecosystem.
The Guide has been distributed through the Baltimore and Washington business journal subscribers, and is being distributed to all regional partners. For your copy of the guide please download here or contact BioHealth Innovation for details on how to receive a hard copy.
back to top
Richard Bendis will speak at the Translational Research Forum during the 2013 BIO International Convention in Chicago. During the forum, speakers will address issues with current translational research models, explore new funding and collaboration opportunities, evaluate how to apply them to federal, academic, and private institutions. The session will take place Monday, April 22, from 4:35 p.m. – 5:25 p.m.
More Information
back to top
Rich Bendis (BHI) and Paul Vulto (MIMETAS) signing the MOU agreement.
MIMETAS is a Dutch microfluidics company focusing on high-throughput organ-on-a-chip systems for predictive toxicology testing, efficacy screening and personalized therapy.
BHI will support MIMETAS by assisting in establishing a MIMETAS US-based subsidiary, aiding in the application for US- and Maryland-based grants (e.g. SBIR, TEDCO), and identifying potential collaborators and partnerships.
This partnership is important in further expanding Maryland's connections internationally and expanding Maryland's biohealth sector.
back to top
BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced its selection of Ram Aiyar, Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) for BHI at the National Institutes of Health’s (NIH) National Heart, Lung and Blood Institute (NHLBI). Dr. Aiyar will help advance fundamental research discoveries to new therapeutics, diagnostics and devices that can be used clinically and commercially.
“We’re pleased to add Dr. Aiyar to our roster of Entrepreneurs-in-Residence,” said Rich Bendis, BHI President and CEO. “He is now our third EIR – joining Todd Chappell, who is EIR at NIH, and Ken Malone, our EIR working with the University of Maryland Ventures. The growth of this program will be a benefit to BHI and our partner organizations for years to come, and will result in transitioning more early-stage biomedical technologies to commercial potential. ”
back to top
- Multiple SBIR/STTR Submission Deadlines Quickly Approaching -
 BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the launch of its Commercial Relevance Program (CRP). BHI's CRP is designed to help life science companies navigate the complicated process of preparing applications for federal funding, inclusive of Small Business Innovation Research (SBIR), Small Business Technology Transfer (STTR), and other federal government awards.
"The federal grant application process can be very complex. Based on 2012 data released by the National Institutes of Health (NIH), Maryland ranks 32nd out of 50 states with regard to SBIR award success rates. We would like to improve on this – and are confident that the CRP will help companies be more successful with their submissions," said Ethan Byler, Director, Innovation Programs, BioHealth Innovation, Inc.
"At the end of the day, it's about helping Central Maryland companies to get the best results possible as they seek out federal grant awards as a means of non-dilutive funding," he added.
The CRP incorporates a pre-proposal review by knowledgeable BHI staff and advisors prior to a life science company's submission of a full proposal. Through this review process, applicants will receive a set of recommendations and tips for troubleshooting their proposal for federal funding.
Interested life science companies in Central Maryland should contact BHI today for more information. The following federal agency SBIR/STTR deadlines are fast approaching:
About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a regional innovation intermediary focused on commercializing market-relevant bio-health innovations and increasing access to early-stage funding in Maryland. Learn more at www.biohealthinnovation.org.
back to top
Blue Button Plus (Automated and Interoperable Blue Button) can provide a technology path for startups and innovators to build new products and services to help Americans with their health. But beyond, technology startups and small businesses have to think about practical matters like funding. What are ways that the federal government is trying to help health startups, particularly health tech startups, develop and commercialize businesses?
The Small Business Innovation Research (SBIR) program is a federally-funded program encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization. Through a competitive awards-based program, SBIR enables small businesses to explore their technological potential and provides the incentive to profit from its commercialization. By including qualified small businesses in the nation’s R&D arena, high-tech innovation is stimulated and the United States gains entrepreneurial spirit as it meets its specific research and development needs.
back to top
by Joseph P. Allen and Diane Palmintera
 On May 20, 2013, the White House Lab-To-Market Inter-Agency Summit was held in Washington, D.C. The Summit was organized by the White House Office of Science and Technology Policy and the National Institutes of Health's Heart, Lung, and Blood Institute. The purpose of the meeting was extraordinary: asking national experts outside of the federal agency system to recommend ways to increase the return-on-investment for the $140 billion annual taxpayer expenditure on federally-funded research and development.
The format for the meeting also was unusual. Research agencies nominated 20 national experts experienced in various phases of technology commercialization to participate in the Summit. The Administration placed no preconditions or limitations on the expert Panel and asked it to focus on "transformative" ideas. We were privileged to be asked to serve as the Summit's co-chairs.
The Administration requested that the Panel address several overarching questions:
- How can agencies better align themselves to more effectively promote the commercial development of their research;
- How can effective metrics for various stages of these efforts be developed; and
- How can we better leverage multi-agency resources to enhance the public's return-on-investment through the commercialization of more federally-funded technologies?
back to top
Scott Carmer (BHI Board Chair), Jerry Parrott, and Rich Bendis (BHI CEO)
On January 24th, 2013 BioHealth Innovation, Inc. (BHI) recognized Jerry Parrott, formerly with Human Genome Sciences, for his contributions as a BHI Founding Board member. He served on the board from 2011 to 2013 and will continue to remain active on BHI's Commercial Relevance Advisory Board (CRAB). We thank Jerry for his service and look forward to a long lasting relationship.
back to top
The Economic Alliance of Greater Baltimore (EAGB) and BioHealth Innovation (BHI) in collaboration with the Baltimore Business Journal are proud to announce the publication of the Central Maryland BioHealth Entrepreneur’s Resource and Financing Guide.
This Guide will be a compendium of resources to BioHealth innovators and entrepreneurs working to start and grow new companies in the region. A wealth of resources exists in Maryland to support emerging BioHealth companies, however, they are not always readily accessible or captured in one place. The Guide will compile information on financial resources, university facilities and programs, economic development programs, and existing federal laboratory facilities and programs and how to work with them.
back to top
On the evening of April 15 as part of the InvestMaryland Challenge Award ceremony held at MICA in Baltimore, BHI presented three awards to local companies. Boss Medical LLC of Baltimore, ConverGene LLC of Gaithersburg, and Vasoptic Medical LLC of Columbia were selected for the awards based upon their high quality products under development, which have good possibility for securing federal funding with support and assistance. Each award – valued at $2,500 – consists of consulting services from BHI on Small Business Innovation Research (SBIR) or federal funding proposals. The SBIR program is designed to support small businesses in commercializing their technological research efforts.
For more information contact Ethan Byler.
back to top
The Global Virus Network plans to move its headquarters to the University of Maryland BioPark in Baltimore, officials announced Thursday.
Emerging pandemic viral threats and current viral killers are a worldwide problem. For this reason, the nonprofit GVN brings together the top medical virologists from more than 30 institutions in 21 countries, to promote international collaborative research, education and advocacy.
back to top
By Eve Green
Last week, the Baltimore BioPark played host to the Innovation Working Group, which consists of executives from the U.S.-Russia Bilateral Presidential Commission. The commission was founded as a joint venture between President Barack Obama and Russian President Dmitry Medvedev.
The highly anticipated event is an opportunity for the United States and Russia to find new ways to collaborate on projects in the fields of biotech and science. Members of the group were given a tour of the University of Maryland, College Park and Baltimore BioPark. The event was led by Oleg Fomichev, the Russian Deputy Minister of Economy, and Lorraine Hariton, Special Representative for Business and Commerce of the U.S. Department of State. Among those that joined the three day tour were chief executives of biotech companies from both Maryland and Russia, as well as leaders from the Pushchino BioTech Cluster.
back to top
 BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced its selection of Ken Malone, Ph.D., of Early Charm Ventures, as the first BHI Entrepreneur-in-Residence (EIR) assigned to work directly with UM Ventures. Dr. Malone, a serial entrepreneur who has founded or been an officer of five biotechnology or advanced materials companies, will help advance the commercialization efforts of new start-up companies based upon innovative discoveries coming out of research programs at the University of Maryland (UMD) College Park and Baltimore.
“We’re thrilled to name Ken Malone as an EIR,” said Richard Bendis, BHI President & CEO. “Ken and I have a long history of working together, so I know first hand that he has the experience, drive and perspective to be a true asset to BHI and to the many start-ups he’ll serve from University of Maryland in support of the newly launched UM Ventures initiative.” Dr. Malone will assist any interested UM start-ups once they have been launched.
back to top
- Technology Company Awarded Prize at Invest Maryland Challenge Ceremony -
 BALTIMORE, MD, April 16, 2013 – University of Maryland (UM) Ventures, an ambitious joint research commercialization effort of the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP), announced today that it has awarded the first UM Ventures Start-Up Prize to VisiSonics, an Investment Maryland Challenge Semi Finalist company that was founded on intellectual property owned by the University. VisiSonics was recognized during the Invest Maryland Challenge Award Ceremony on Monday, April 15, 2013 at the Maryland Institute College of Art (MICA) in Baltimore, Maryland.
"Identifying customers and having sales is, of course, a major hurdle for university start-ups," said James L. Hughes, Director of UM Ventures, and President, Research Park Corporation, University of Maryland Baltimore. "With the significance of achieving more than half a million dollars in sales in 2012, VisiSonics is a worthy recipient of this inaugural prize."
back to top
 Richard Moore, BD DiagnosticsROCKVILLE AND BALTIMORE, MARYLAND, August 26, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today its selection of Richard Moore, M.D., Ph.D., as a new Entrepreneur-in-Residence (EIR) at the National Institutes of Health (NIH) Office of Technology Transfer (OTT). BHI and BD established this position in July 2013. Dr. Moore, an executive with decades of experience in diagnostics development and technology strategy, will help support the development of new start-up companies and product commercialization based upon innovative technologies selected via OTT license agreements.
back to top
In this newsletter we proudly present the new Chairman of the Advisory Board: Richard Bendis.
With his expertise on innovation strategy The Technopolicy Network intends to strengthen
its position as the global leading network on Science Based Regional Development and Science Based Incubation. In his article he will give you several insights in the opportunities that lie ahead of us.
This is the time to pay tribute to the achievements of our founding Chairman, Prof. Roger Stough. With his advice and support Prof. Stough made The Technopolicy Network to what it now is. In his article he looks back on the growth of The Technopolicy Network over the past decade.
back to top
The Tech Council of Maryland called on legislators Monday to triple the funding for the state's research and development tax credit and double the scope of its popular biotech tax credit, among other measures.
The Tech Council of Maryland places the expansion of the R&D credit from $6 million to $18 million among its top priorities for the 2013 General Assembly session, which convenes in Annapolis on Wednesday. The measure failed to win approval last year despite passing the Senate. The Tech Council also wants to see that credit made available for companies that haven't yet reached profitability.
back to top
As part of the University of Maryland's 26th Annual Invention of the Year Awards ceremony held at the University of Maryland Golf Course on April 16, BioHealth Innovation sweetened the pot for this year's three award winners. BHI offered each award winner strategic consulting services on federal grants or SBIR awards – valued at $2,500 per company. The BHI Commercial Relevance Program is designed to support small businesses in commercializing their technological research efforts.
The three winning inventions were:
INFORMATION SCIENCE CATEGORY:
Winner:
Time-Reversal Division Multiple Access for Wireless Broadband Communications
Feng Han, Yu-Han Yang, Beibei Wang, Yongle Wu and K. J. Ray Liu
LIFE SCIENCE CATEGORY:
Winner:
A Method for Early Diagnosis of Amyotrophic Lateral Sclerosis (ALS)
Eva Chin and Dapeng Chen
PHYSICAL SCIENCE CATEGORY:
Winner:
A Method for Rapid, Inexpensive Prototyping of Microfluidic Devices
Omid Rahmanian, Donald DeVoe
More Information
back to top
The INNo program trains research scientists in the entrepreneurial skills needed to bring technology inventions and services to the healthcare market.
Participants in the INNo program learn to:
- Identify and evaluate the commercial potential of intellectual property
- Understand the business fundamentals related to technology start-ups
- Create a value proposition and business concept for a new product, platform, or service
- Articulate investment opportunities persuasively to potential investors and partners
- Develop a network of resources in the Maryland entrepreneurial community
back to top
Emergent Biosolutions Inc.  said it has secured exclusive right to manufacture and sell VaxInnate Corp.'s pandemic influenza vaccine candidate in the United States.
Under a license agreement with VaxInnate, Emergent Biosolutions acquired exclusive U.S. commercial rights to next generation pandemic influenza vaccine candidate.
This license enables Emergent to fulfill the requirement to secure a pandemic influenza vaccine candidate under its contract with the Biomedical Advanced Research and Development Authority (BARDA), the company noted.
back to top
Lets collaborate on building a vibrant biotech (or any other) community! Nice chestnut, but how does one design a community that functions across industries, geographies, support organizations, academic institutions and federal labs, each with very different missions and views of their (and others’) roles? How do you find a shared vision for these variant groups, one that drives growth for the greater region and doesn’t cause the players for fight over each opportunity as if it is the last scrap of possibility we’ll see? How do you prevent such a vision from becoming another dusty whitepaper, where behaviors weren’t aligned to make it happen? I had a chance to discuss how such a collaboration should be designed with Rich Bendis, President & CEO of BioHealth Innovation (BHI), an organization which spans from Rockville to Baltimore.
back to top
 ROCKVILLE, MARYLAND, March 4, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, today announced that BioHealth Innovation, Inc. President & CEO Richard Bendis is scheduled to present at the upcoming SXSW 2013 conference and the 2013 BIO International Convention this Spring. Mr. Bendis is also serving on the Program Committee for AdvaMed 2013: The MedTech Conference, which will be held in Washington, DC, in September.
Specific information for each event is as follows:
- 2013 South By Southwest "SXSW" Conference, March 8-12, 2013, Austin Convention Center, Austin, Texas. Mr. Bendis is participating in a panel on Saturday, March 9, entitled, "Entrepreneurs-in-Residence: Not Just for VCs!" Venture capital firms have utilized the services of 'Entrepreneurs-in-Residence' (EIRs), seasoned innovators with functional expertise, to help spur entrepreneurship and fill gaps in expertise. This panel will look at the value of combining the 'innovation mojo' of EIRs with some of the government's brightest 'intrapreneurs' to solve the nation's most pressing challenges. Joining Mr. Bendis on the panel will be Arnaub Chatterjee (Associate Director of Health Information Partnerships, Merck - Office of the Chief Medical Information and Innovation Officer), John Paul Farmer (Senior Advisor to the U.S. CTO) and Zachery Jiwa, Health IT Advisor; Innovation Fellow, U.S. Department of Health and Human Services; Advisor, HIMSS State Advisory Roundtable.
- 2013 BIO International Convention, April 22-23, 2013, McCormick Place, Chicago, Illinois. Mr. Bendis is scheduled to be part of The Translational Research Forum on April 22, 2013, beginning at 1:30 p.m., and a panel discussion focused on effective strategies in developing accelerator models beginning at 4:35 p.m.
- AdvaMed 2013: The MedTech Conference, September 23-25, 2013, Walter E. Washington Convention Center, Washington, DC. Mr. Bendis is reviewing panel submissions in the eHealth IT Track.
back to top
Montgomery officials are under no illusions about the county’s image among the Washington region’s young: boring.
“We’re a little sleepy,” said County Council member Roger Berliner (D-Potomac-Bethesda). “We go to bed early.”
For all its prosperity and family-friendly suburban appeal, Montgomery is in the throes of a midlife crisis. That angst has led to a new item at the top of the public policy agenda: a yearning to be hip.
back to top
Partnership with Johns Hopkins and BioHealth Innovation, Inc. will speed 10 healthtech startups to market
Baltimore, MD and Philadelphia, PA — September 18th, 2013—DreamIt Ventures is pleased to announce the launch of DreamIt Health Baltimore, a partnership with The Johns Hopkins University and BioHealth Innovation, Inc. to recruit, invest in, and speed the growth and success of a select group of early-stage health IT companies. The program comes on the heels of a successful health IT program in Philadelphia also built on strong industry partnerships that give participants access and advantages typically out-of-reach to startups.
"The key to making health care more accessible is innovation, and the most fertile focus for health care innovation is in acquiring, storing, analyzing and sharing information," said Ronald J. Daniels, President of Johns Hopkins. "This accelerator project will have important implications for the future use of information as we use technology to find solutions for the most pressing health problems of our day. Just as important, it sets up Baltimore to become even more central to the health care information revolution through the rapid validation of solutions."
"Technology holds the potential to transform the way in which we approach health care in this country and around the world," said Paul Rothman, MD, Dean of the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine. "Johns Hopkins has been at the forefront in developing innovative solutions to the most pressing health care challenges. The partnership with DreamIt presents an exciting and unrivaled opportunity to develop the most cutting-edge solutions at the crossroads of information technology and medicine."
back to top
British healthcare firm GlaxoSmithKline has filed for US regulatory approval of its new type 2 diabetes drug albiglutide, which belongs to the same group of injectable GLP-1 receptor agonists as Byetta, Bydureon and Victoza .
GSK announced on Monday that it had submitted the once-weekly medication to the US Food and Drug Administration (FDA) for approval and confirmed that it also plans to seek European Union regulatory approval for the new product in 2013.
back to top
In 1953, Cambridge researchers Watson and Crick published a paper describing the interweaving ‘double helix’ DNA structure – the chemical code for all life.
Now, in the year of that scientific landmark’s 60th Anniversary, Cambridge researchers have published a paper proving that four-stranded ‘quadruple helix’ DNA structures – known as G-quadruplexes – also exist within the human genome. They form in regions of DNA that are rich in the building block guanine, usually abbreviated to ‘G’.
back to top
The NHLBI Division of Extramural Research Activities (DERA) is pleased to announce the addition of Dr Lawrence Mahan, as the Director of the Office of Translational Alliances and Coordination (OTAC). Dr. Mahan’s professional experience spans academia, government and industry in both basic and applied biomedical research. Additionally it includes global business and strategic alliance development, strategic planning, technology evaluation, entrepreneurship guidance, and consulting on platform technology development in the life sciences.
Most recently Dr. Mahan served as Director of Innovation and Business Development for Children’s National Medical Center and its research institutes, the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, where he managed intellectual property, strategic business alliance development and the advancement of academic entrepreneurship.
back to top
 Our Entrepreneur-in-Residence Ram Aiyar participated in a tech transfer series featured on BioCentury This Week discussing the need for accelerated innovations and the current lack of commercialization focus on commercially relevant technologies. The program was divided into 3 parts, Stuck in the Lab, Fresh Approaches, and Validation and also featured Dr. Alicia Loeffler and Rosemarie Truman.
The three-part program can be watched by following the link below.
![BioCentury 10.13.13 - [1] Stuck in the Lab](http://www.biocenturytv.com/images/marquees/marq_101313_play.png)
Stuck in the Lab
back to top
McLean-based Science Applications International Corp., which announced plans in August to split off part of its operations into a separate publicly traded company, has decided on a name for the new business.
The spinoff, which will focus on national security, health and engineering, will be called Leidos.
back to top
Time-reversal techniques for optimizing broadband communication networks and rapid prototyping of microfluidics devices were among the Clark School of Engineering inventions recognized as the most promising new technologies at the University of Maryland Invention of the Year Awards.
The University of Maryland’s Office of Technology Commercialization (OTC) hosted the 26th Annual Invention of the Year Awards reception on Tuesday, April 16, 2013 from 4:30-6:00 pm at the University of Maryland Golf Course Club House.
back to top
The INNo program trains research scientists in the entrepreneurial skills needed to bring technology inventions and services to the healthcare market.
Participants in the INNo program learn to:
- Identify and evaluate the commercial potential of intellectual property
- Understand the business fundamentals related to technology start-ups
- Create a value proposition and business concept for a new product, platform, or service
- Articulate investment opportunities persuasively to potential investors and partners
- Develop a network of resources in the Maryland entrepreneurial community
back to top
|
